Seeing Is Believing
Currently out of the existing stock ratings of Wangzhi Li, 12 are a BUY (80%), 3 are a HOLD (20%).
Analyst Wangzhi Li works with a stock forecast success ratio of 65% fulfilled within 186.4 days on average. Previously, Wangzhi Li worked at LADENBURG.
Wangzhi Li’s has documented 32 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BGNE, BeiGene Ltd at 08-Dec-2020.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 3/4/2020. The price target of $28 was fulfilled within 54 days with a profit of $11.22 (66.87%) receiving and performance score of 12.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
345
$189.92 (122.47%)
350
1 months 1 days ago
2/5 (40%)
$165.31 (92.00%)
350
Buy
285
$129.92 (83.78%)
290
5 months 2 days ago
0/3 (0%)
$119.15 (71.84%)
Hold
212
$56.92 (36.70%)
263.3
6 months 8 days ago
1/2 (50%)
$19.16 (9.94%)
1
Buy
319
$163.92 (105.70%)
321
6 months 28 days ago
3/9 (33.33%)
$105.41 (49.35%)
126
Buy
1 years 21 days ago
1/1 (100%)
$64.01 (47.07%)
249
What Year was the first public recommendation made by Wangzhi Li?